Denna sida på svenska
Loading profile information...

About me

2002-2007   MD, Linköping University, Sweden

2004-2008   PhD, Linköping University, Sweden

2009-2016   Postdoc and Researcher, Statens Serum Institut, Copenhagen, Denmark

2016-           Senior Researcher, Karolinska Institutet

2017-           Associate Professor (docent), Karolinska Institutet

 

Research description

Thriving on substantial expertise in large-scale register studies of adverse drug effects, we have the overall objective of using high-quality epidemiology to help inform evidence-based decisions in clinical practice. We are currently launching research programs in pediatric pharmacoepidemiology and the area of expedited assessment of current drug safety concerns. My group’s scope is not limited to one single disease entity or therapeutic area; rather, we are in a constant process of seeking out and addressing emerging drug safety concerns with implications for clinical practice.  

 

I have recently joined Karolinska Institutet following a long period of service at Statens Serum Institut in Copenhagen and am building up a research team. Young academics as well as seasoned researchers looking to pursue research that aims to advance the safe use of medications in clinical practice are welcome to contact us!

 

Team members

 

Our research is funded by

  • Swedish Research Council
  • Swedish Cancer Society
  • Swedish Heart-Lung Foundation
  • Thrasher Research Foundation
  • Novo Nordisk Foundation
  • Nordic Cancer Union
  • Swedish Diabetes Foundation 
  • Strategic Research Area Epidemiology (SfoEpi) at Karolinska Institutet
  • Karolinska Institutet Foundations and Funds
  • Stiftelsen Frimurare Barnhuset
  • Åke Wibergs Stiftelse

 

Selected publications

Scheller NM, Pasternak B, Mølgaard-Nielsen D, Svanström H, Hviid A. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes. New England Journal of Medicine 2017

 

Molgaard-Nielsen D, Svanstrom H, Melbye M, Hviid A, Pasternak B. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA 2016

 

Scheller NM, Svanstrom H, Pasternak B, Arnheim-dahlstrom L, Sundstrom K, Fink K, et al. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA 2015

 

Scheller NM, Pasternak B, Svanstrom H, Hviid A. Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism. JAMA 2014

 

Nyboe Andersen N, Pasternak B, Basit S, Andersson M, Svanstrom H, Caspersen S, et al. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA 2014

 

Feenstra B, Pasternak B, Geller F, Carstensen L, Wang T, Huang F, et al. Common variants associated with general and MMR vaccine-related febrile seizures. Nature genetics 2014

 

Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. New England Journal of Medicine 2013

 

Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New England Journal of Medicine 2013

 

Svanstrom H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. New England Journal of Medicine 2013

 

Pasternak B, Svanstrom H, Melbye M, Hviid A. Association between oral fluoroquinolone use and retinal detachment. JAMA 2013

 

Pasternak B, Svanstrom H, Molgaard-nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013

 

Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. New England Journal of Medicine 2013

 

Pasternak B, Svanstrom H, Molgaard-nielsen D, Krause Tg, Emborg Hd, Melbye M, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012

 

Pasternak B, Svanstrom H, Molgaard-nielsen D, Krause Tg, Emborg Hd, Melbye M, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012

 

Svanstrom H, Pasternak B, Hviid A. Association of treatment with losartan vs candesartan and mortality among patients with heart failure. JAMA 2012

 

Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010

 

Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. New England Journal of Medicine 2010

Loading publication list...